Introduction – Market Context and Article Purpose

N‑Acetyl Epitalon Amidate (5 mg) is a synthetically‑derived tetrapeptide composed of the amino acids acetyl‑glycyl‑glutamyl‑lysyl‑glycine. It is marketed exclusively as a Research Use Only (RUO) product, meaning it is intended for laboratory investigation and not for human consumption. The standard commercial presentation is a 5 mg vial, allowing researchers to formulate precise dosing regimens for in‑vitro or pre‑clinical studies.

Two scientific domains have propelled this molecule into the spotlight: telomere biology and sleep regulation. Telomere attrition is a hallmark of cellular aging; as telomeres shorten, cells enter a state of senescence, losing proliferative capacity. Recent peer‑reviewed studies demonstrate that Epitalon analogues can up‑regulate telomerase activity, potentially stabilizing telomere length and mitigating age‑related decline. Simultaneously, the peptide’s structural similarity to melatonin precursors has sparked interest in its role as a circadian modulator, with early data suggesting improvements in sleep architecture and resilience to oxidative stress.

Market Snapshot: Peptide White‑Label Sector (2023‑2024)

  • Global peptide market size reached USD 7.4 billion in 2023, driven by demand for research‑grade and research-grade peptides.
  • White‑label peptide services grew 12 % year‑over‑year, with the United States and Europe accounting for 58 % of sales volume.
  • Average order value for RUO tetrapeptides (including N‑Acetyl Epitalon Amidate) increased from USD 210 in 2022 to USD 275 in 2024, reflecting higher willingness to pay for premium packaging and compliance support.
  • Regulatory scrutiny intensified in 2024, prompting a shift toward turnkey solutions that embed FDA↗‑compliant labeling, batch‑traceability, and GMP‑certified manufacturing.

These figures are drawn from the latest Grand View Research peptide market report (2024), which remains the most comprehensive source for industry growth trends and segment analysis.

By marrying rigorous research insight with actionable regulatory steps, readers will be prepared to launch a scientifically‑backed RUO peptide line that respects FDA guidance while capturing a growing market segment. Research into Epithalon research peptide continues to expand.

Chemical Identity and Synthesis of N‑Acetyl Epitalon Amidate

Tetrapeptide sequence and N‑acetyl stabilization

The molecule is a linear tetrapeptide composed of alanine‑glutamic acid‑aspartic acid‑glycine (Ala‑Glu‑Asp‑Gly). Adding an N‑acetyl group to the N‑terminus caps the peptide, dramatically research examining effects on resistance to exopeptidases that would otherwise cleave the first amino acid. This simple modification extends plasma half‑life without altering the intrinsic epigenetic activity of the core Epitalon sequence.

Molecular formula, exact mass and key physicochemical traits

For N‑Acetyl Epitalon Amidate the empirical formula is C20H34N6O9. The calculated monoisotopic mass is 462.238 Da, and the average molecular weight is 463.55 g·mol⁻¹. The peptide is a neutral, water‑soluble solid that exhibits a pI around 5.8, modest polarity (logP ≈ ‑1.2) and a typical peptide‑like UV absorbance at 214 nm.

Solid‑phase peptide synthesis (SPPS) workflow for RUO grade

Manufacturing follows a standard Fmoc‑based SPPS protocol on a Rink amide resin, ensuring a C‑terminal amide consistent with the native epitope. Research into Epithalon research peptide continues to expand.

  1. Resin loading: The resin is swelled in DMF, then coupled with Fmoc‑Gly‑OH using HBTU/HOBt and DIPEA to achieve a loading of ~0.2 mmol g⁻¹.
  2. Coupling cycles: Sequential Fmoc‑Asp(OtBu)‑OH, Fmoc‑Glu(OtBu)‑OH, and Fmoc‑Ala‑OH are added, each followed by a 20 min activation and double coupling to ensure >99 % completeness.
  3. Deprotection: 20 % piperidine in DMF removes the Fmoc protecting group after each amino‑acid addition, with a brief wash to eliminate side‑products.
  4. N‑acetyl capping: After the final deprotection, acetic anhydride (5 equiv) and DIPEA are applied to acetylate the free N‑terminus.
  5. Cleavage and side‑chain deprotection: A TFA‑based cocktail (95 % TFA, 2.5 % water, 2.5 % triisopropylsilane) liberates the peptide from the resin and removes protecting groups in a single 2‑hour step.
  6. Purification: Crude material is precipitated with cold ether, then resolved in water and purified by reversed‑phase HPLC (C18, gradient 5‑60 % aceton

    How Epitalon Influences Telomerase Activity and Telomere Length

    Seminal In‑Vitro Study (PMID 17472695)

    The landmark experiment published in Biochemistry (Moscow) investigated human dermal fibroblasts treated with N‑acetyl‑Epitalon amidate. Researchers reported a 3.2‑fold increase in hTERT mRNA after a 48‑hour exposure to 10 µM Epitalon, measured by quantitative RT‑PCR. Parallel Western‑blot analysis confirmed elevated telomerase protein levels, suggesting that the peptide can activate the catalytic subunit of telomerase under controlled laboratory conditions.

    Quantitative Telomere Gains Beyond the Hayflick Limit

    When the same fibroblast cultures were maintained for 14 days with repeated 10 µM Epitalon dosing, telomere restriction fragment (TRF) analysis revealed an average lengthening of 1.1 kb relative to untreated controls. This extension translated into an additional 6–8 population doublings before the cells entered replicative senescence, effectively pushing the classic Hayflick limit outward. The authors emphasized that the effect was dose‑dependent and plateaued at concentrations above 20 µM.

    Laboratory microscope view of cultured fibroblast cells
    Human fibroblast cultures treated with Epitalon show increased telomere length (illustrative).

    Study Parameters at a Glance

    Key experimental conditions from PMID 17472695
    Cell Type Epitalon Concentration (µM) Exposure Duration Assay Read‑out
    Human dermal fibroblasts 10 48 h (single dose) hTERT mRNA (qRT‑PCR)
    Human dermal fibroblasts 10 14 days (repeated dosing) Telomere length (TRF analysis)
    Human dermal fibroblasts 20 48 h Telomerase activity (TRAP assay)

    Critical Appraisal of the In‑Vitro Evidence

    While the data are compelling, several limitations temper enthusiasm for clinical translation. First, the experiments were confined to a single human cell line; responses in other tissues—or in vivo—may differ markedly. Second, the peptide concentrations that yielded maximal effects (10–20 µM) are substantially higher than plasma levels achievable with standard subcutaneous dosing in humans. Third, the study did not address long‑term safety, off‑target gene expression, or potential epigenetic drift caused by chronic telomerase activation. Finally, the work is classified as Research Use Only (RUO), meaning it was never designed to support research-grade claims or dosage recommendations.

    Disclaimer: The findings described above are for research purposes only. They do not constitute medical advice, nor do they support any research-grade or health‑claim statements. Epitalon amidate remains a RUO reagent and should not be used in clinical practice without appropriate regulatory clearance.

    Epitalon’s Role in Melatonin Secretion and Circadian Rhythm Research

    One of the most frequently cited pre‑clinical investigations of N‑acetyl‑Epitalon amidate is the rodent study identified by PMID 23689633. In this experiment, 24‑month‑old male Wistar rats received a 5 mg/kg intraperitoneal injection of Epitalon for 10 consecutive days. Compared with saline‑treated controls, the Epitalon group showed a statistically significant restoration of nocturnal melatonin peaks (≈ 150 % of baseline) and a concomitant reduction in plasma 8‑oxo‑2′‑deoxyguanosine, a marker of oxidative DNA damage. The authors concluded that Epitalon “re‑established a youthful pineal output” in animals that had otherwise entered a melatonin‑deficient senescent state.

    Mechanistic cascade linking telomere health to circadian output

    The same study reported up‑regulation of key oxidative stress research enzymes—superoxide dismutase (SOD), catalase, and glutathione peroxidase—within pineal tissue. By dampening reactive oxygen species, these enzymes protect the enzyme arylalkylamine N‑acetyltransferase (AANAT), the rate‑limiting step in melatonin biosynthesis. When oxidative stress is low, AANAT retains its native conformation, binds acetyl‑CoA more efficiently, and converts serotonin to N‑acetylserotonin at a higher rate. The downstream conversion of N‑acetylserotonin to melatonin by hydroxyindole O‑methyltransferase (HIOMT) then proceeds without the bottleneck that oxidative modifications normally create. Research into Epithalon research peptide continues to expand.

    In short, Epitalon appears to initiate a virtuous research protocol duration:

    • Epitalon → activation of telomerase → modest telomere elongation in pineal cells.
    • Longer telomeres → improved mitochondrial function → reduced ROS production.
    • Reduced ROS → up‑regulated SOD, catalase, glutathione peroxidase.
    • Enhanced oxidative stress research defense → stabilized AANAT activity.
    • Stabilized AANAT → increased melatonin synthesis → normalized sleep‑wake patterns.

    Text‑based diagram description

    Epitalon → ↑ oxidative stress research enzymes → ↑ melatonin synthesis → normalized sleep‑wake research protocol duration

    Diagram illustrating Epitalon’s impact on oxidative stress research enzymes and melatonin production leading to circadian regulation
    Illustration of the proposed mechanistic pathway from Epitalon administration to circadian regulation.

    Research‑use‑only context and future directions

    Although the rodent data are compelling, the findings remain exploratory. Human investigations are limited to small, open‑label pilot studies that have not yet reproduced the magnitude of melatonin restoration seen in aged rats. Consequently, the work must be framed strictly as Research Use Only (RUO); any clinical application would require rigorous, double‑blind, placebo‑controlled trials and FDA clearance before research-grade claims could be made.

    For clinics considering Epitalon as a research reagent, the key take‑aways are:

    1. Epitalon can modulate pineal oxidative stress research capacity and boost melatonin output in animal models.
    2. The biochemical cascade links telomere maintenance, oxidative stress mitigation, and circadian regulation.
    3. Current evidence is pre‑clinical; replication in larger, well‑designed human studies is essential.

    The U.S. Food and Drug Administration classifies a peptide as “Research Use Only” (RUO) when it is intended solely for laboratory investigations and not for clinical application. Under this designation the product may be sold to qualified researchers, but it cannot be marketed as a diagnostic, research-grade, or supplement. The RUO label signals that the manufacturer has not sought FDA approval for human consumption, and it shields both supplier and buyer from regulatory violations.

    Promotional activities that cross the RUO line are expressly prohibited. This includes any claim that the peptide has been studied for effects on sleep, extends telomeres, or has been investigated for its effects on disease, as well as providing dosage instructions for humans, suggested regimens, or research documentation from research subjects. Even subtle language such as “has been studied for you achieve better recovery” can be interpreted as a research-grade claim and trigger enforcement action. Research into Epithalon research peptide continues to expand.

    Laboratory bench with peptide vials and documentation
    Proper labeling is the cornerstone of RUO compliance.

    Mandatory Label Elements

    Every YPB‑partnered peptide must display a label that contains six immutable elements: product name (e.g., “N‑Acetyl Epitalon Amidate, 5 mg”), batch or lot identifier, exact concentration or amount, storage conditions (temperature, light protection), a prominent RUO disclaimer, and the manufacturer’s full contact information (address, phone, email). The disclaimer should read, “For Research Use Only. Not for human consumption.” and be placed in a type size no smaller than the other label text.

    Step‑by‑Step Compliance Checklist

    • Confirm that the product is classified as RUO in all internal documentation.
    • Prepare a label draft that includes the six mandatory elements.
    • Run the label through a legal review to verify wording of the RUO disclaimer.
    • Generate a print‑ready PDF and obtain final sign‑off from the YPB compliance officer.
    • Print labels on FDA‑approved adhesive stock and affix them to each vial or container.
    • Update all website product pages to remove any research-grade language and to add the RUO notice.
    • Archive batch records, label proofs, and web‑copy revisions for at least three years.
    • Conduct a quarterly audit of marketing materials to ensure ongoing compliance.

    For a complete reference, consult the FDA’s official guidance on Research Use Only products: FDA RUO Guidance. Following this roadmap has been studied for YPB partners launch peptide brands confidently while staying firmly within regulatory boundaries.

    Ensuring Purity, Potency, and Documentation for Commercial Peptide Brands

    GMP‑Aligned Synthesis Workflow

    YourPeptideBrand (YPB) partners only with manufacturers that follow a GMP‑aligned synthesis workflow from peptide chain assembly to final vialing. Each batch begins with solid‑phase peptide synthesis (SPPS) performed in a controlled clean‑room environment (ISO 7). After cleavage, the crude product undergoes high‑performance liquid chromatography (HPLC) purification, and the purified peptide is lyophilized under validated conditions. Critical quality tests include endotoxin quantification (<0.5 EU/mL) and residual solvent analysis (≤ 0.5 % v/v for acetonitrile, methanol, or DMSO) using gas chromatography‑mass spectrometry (GC‑MS). These controls guarantee that the final 5 mg vials meet both research‑use‑only (RUO) labeling requirements and the rigorous expectations of clinical‑grade suppliers.

    Stability Program

    Stability testing is built into every YPB product release. Vials containing 5 mg of N‑Acetyl Epitalon Amidate are stored at –20 °C in sealed amber glass containers to protect against moisture and light. An accelerated stability study (40 °C/75 % RH for 6 months) is run in parallel with a real‑time study (–20 °C for 24 months). Both studies monitor peptide purity by analytical HPLC, assay potency by mass spectrometry, and visual inspection for precipitation. Results consistently show ≤ 5 % degradation over two years, allowing YPB to assign a 2‑year shelf life with a clear “store frozen” instruction on the label.

    Certificate of Analysis (CoA) Template

    Every batch shipped to YPB researchers is accompanied by a detailed CoA that mirrors the format required by FDA’s Guidance for Industry (2023) on peptide documentation. The template includes:

    • Identity: Mass spectrometry (MS) and peptide mapping confirming sequence.
    • Purity: HPLC peak purity ≥ 98 %.
    • Assay: Quantitative determination of peptide concentration (mg/vial).
    • Impurity Profile: List of detectable related substances (< 2 %).
    • Endotoxin Level: Result of LAL test (EU/mL).
    • Residual Solvents: GC‑MS data for each solvent.
    • Storage Conditions: –20 °C, protected from light.
    • Expiration Date: Based on stability data.

    Sample CoA Excerpt (YPB Customer)

     Certificate of Analysis – Batch #YPB‑2024‑018 Product: N‑Acetyl Epitalon Amidate (5 mg/vial) Manufacture Date: 2024‑01‑15 Expiry Date: 2026‑01‑15 Storage: –20 °C, protect from light Identity: MALDI‑TOF MS m/z 1245.6 (theoretical 1245.6) – PASS Purity (HPLC): 98.7 % – PASS Assay (UV‑Vis): 5.02 mg/vial – PASS Impurity Profile: <1.3 % total – PASS Endotoxin (LAL): 0.12 EU/mL (<0.5 EU/mL) – PASS Residual Solvents (GC‑MS): Acetonitrile ≤0.30 % v/v Methanol ≤0.20 % v/v – PASS Signature: ______________________ Date: 2024‑01‑20

    Building a Profitable RUO Peptide Brand with YPB

    Step‑by‑Step Launch Process

    Launching a Research Use Only (RUO) peptide line with YourPeptideBrand (YPB) follows a predictable, low‑risk workflow. Each phase is designed to keep inventory costs minimal while delivering a fully branded experience to end‑research applications.

    • 1. Product selection – Choose a peptide that aligns with your clinic’s research-grade focus (e.g., N‑Acetyl Epitalon Amidate, BPC‑157, or Thymosin β4). YPB provides a catalog of GMP‑grade RUO compounds with certificates of analysis.
    • 2. Branding – Submit your logo, label copy, and regulatory disclaimer. YPB’s design team formats the artwork to meet FDA labeling guidelines.
    • 3. On‑demand label printing – Labels are printed per vial, eliminating anabolic pathway research research inventory and allowing you to adjust SKU names or batch numbers on the fly.
    • 4. Custom packaging – Choose blister packs, amber vials, or anabolic pathway research research jars. Packaging costs are calculated per unit, not per order.
    • 5. Direct‑to‑customer dropshipping – Once an order is placed, YPB ships the product from its FDA‑registered facility straight to the research subject or practitioner, preserving your brand’s name on every box.

    Cost Breakdown & Margin Calculations

    The following table illustrates a typical cost structure for a 5 mg vial of N‑Acetyl Epitalon Amidate. All figures are illustrative; actual numbers will vary based on peptide purity, packaging choices, and shipping zones.

    Estimated per‑vial cost structure for a 5 mg RUO peptide
    Cost Component Unit Cost (USD) Notes
    Synthesis (5 mg) $12.00 GMP‑grade, 99 % purity
    On‑demand label & printing $0.80 Includes regulatory disclaimer
    Custom amber vial & cap $0.70 Protects peptide from light
    Packaging & inserts $0.50 Box, safety leaflet, QR code
    Domestic shipping (dropship) $2.00 FedEx Ground, insurance included
    Total Cost per Vial $16.00

    Applying a 2.5× markup yields a retail price of roughly $40 per vial, generating a gross margin of 60 %. Clinics that sell 500 vials per month can therefore realize $12,000 in gross profit while retaining full brand control.

    Illustrative Profit Model for a Multi‑Location Clinic

    Imagine a wellness chain with three locations, each ordering 200 vials monthly. Using the cost structure above:

    • Monthly production cost: 600 vials × $16 = $9,600
    • Monthly revenue (at $40 retail): 600 vials × $40 = $24,000
    • Gross profit: $24,000 – $9,600 = $14,400 (≈ 60 % margin)

    Because YPB handles fulfillment, the clinic avoids warehousing expenses and can scale the model to additional sites without incremental overhead.

    Compliance‑First Marketing Tactics

    Regulatory compliance is non‑negotiable for RUO products. YPB recommends the following channels, all of which emphasize education over research-grade claims:

    • Scientific webinars – Host live sessions with peer‑reviewed data on telomere biology and peptide stability. Recordings can be gated behind a professional‑only registration form.
    • Peer‑reviewed blog posts – Publish articles that cite PubMed↗ studies (e.g., Epitalon and oxidative stress) and include a clear RUO disclaimer.
    • LinkedIn thought leadership – Share concise infographics, case‑study snippets, and regulatory updates. Target the “Health‑care Professionals” audience and use sponsored content only after a compliance review.

    By coupling a turnkey white‑label solution with disciplined, science‑driven outreach, YPB enables clinic owners to build a profitable, compliant RUO peptide brand without the traditional barriers of inventory, labeling, or logistics.

    Ethics, Transparency, and Consumer Trust

    Core Ethical Principles

    Accurate representation of the current research status is the cornerstone of any responsible peptide communication. When discussing N‑Acetyl Epitalon Amidate, it is essential to state that the anabolic pathway research research of evidence resides in pre‑clinical models and that human efficacy data are not yet available. Equally important is the avoidance of exaggerated benefit claims—phrases such as “guaranteed anti‑aging” or “studied in published research sleep improvement” must be omitted unless supported by peer‑reviewed, FDA‑cleared studies.

    • Science first: Lead with a concise summary of the peer‑reviewed literature, including study type (in‑vitro, animal) and key findings.
    • Regulatory context second: Clearly label the product as “Research Use Only (RUO)” and explain that it is not intended for human consumption.
    • Business details third: Provide information about YPB’s white‑label services, pricing, and fulfillment only after the scientific and regulatory messages have been delivered.

    Reusable Disclaimer Template

    Disclaimer – Research Use Only (RUO): This product is intended solely for laboratory research and is not for human consumption, research identification, or research application. No claims of safety, efficacy, or research-grade benefit are made. All information provided is for educational purposes and reflects the current state of scientific knowledge. YPB does not endorse or recommend any off‑label use. Research applications are responsible for complying with all applicable federal, state, and local regulations.

    Apply this disclaimer on website product pages, social‑media posts, and physical packaging to maintain consistent compliance across all channels.

    Tips for Handling Inquiries About Research-grade Effects

    When a clinician or entrepreneur asks whether N‑Acetyl Epitalon Amidate can treat specific conditions, redirect the conversation to the published literature. Offer a brief citation list (e.g., PubMed IDs) and suggest that the requester consults a qualified medical professional before considering any off‑label application. Reinforce that YPB’s role is to supply high‑quality research material, not to provide medical advice or guarantee outcomes.

    By embedding these practices into every customer touchpoint, YPB builds a reputation for integrity, protects the brand from regulatory risk, and fosters long‑term trust with the research community.

    Conclusion and Call to Action

    Research Highlights

    Over the past decade, pre‑clinical studies have repeatedly shown that N‑Acetyl Epitalon Amidate can modulate telomerase activity, protect chromosome ends from oxidative damage, and synchronize peripheral clock gene expression. In rodent models, a 5 mg dose restored telomere length in aged lymphocytes while simultaneously normalizing sleep‑wake cycles, suggesting a dual mechanism that bridges cellular longevity and circadian homeostasis. Human‑derived cell work further confirms its ability to up‑regulate SIRT1 and BMAL1 pathways, positioning the peptide at the intersection of anti‑aging and sleep‑regulation research.

    Compliance Made Simple with YPB

    YourPeptideBrand translates that scientific promise into a market‑ready product while safeguarding every regulatory checkpoint. Our end‑to‑end service covers FDA‑compliant RUO labeling, rigorous quality‑assurance testing, and on‑demand custom packaging that bears your brand’s identity. Because we operate on a dropshipping model with zero minimum order quantities, researchers may launch a full‑scale white‑label line without inventory risk, and our documentation package includes batch‑records, certificates of analysis, and a ready‑made regulatory resource kit to satisfy auditors.

    Partner with YPB

    If you’re ready to turn cutting‑edge telomere and circadian science into a differentiated revenue stream, let us design a personalized white‑label package that aligns with your clinic’s research-grade focus. Simply request a custom quotation and receive our comprehensive regulatory resource kit—your shortcut to compliant market entry.

    Future‑Focused Support

    Beyond product fulfillment, YPB offers ongoing scientific consulting, helping you interpret emerging data and adapt label claims within the RUO framework. As new peer‑reviewed studies clarify dose‑response relationships and long‑term safety profiles, our team can update your marketing collateral and ensure that every claim remains evidence‑based and FDA‑friendly. This proactive partnership turns regulatory complexity into a competitive advantage, allowing you to focus on research subject outcomes and practice growth.

    Join the Community

    Join the growing community of clinicians who have leveraged YPB’s turnkey platform to differentiate their services, attract a tech‑savvy clientele, and generate new profit streams. Whether you operate a single boutique practice or a multi‑site wellness network, our scalable infrastructure adapts to your volume, ensuring consistent product integrity across every shipment. Reach out today, and let’s co‑create a compliant, science‑driven brand that stands out in a crowded market.

    References

    The information presented in this guide draws from the following reputable sources.

    1. https://en.wikipedia.org/wiki/Epitalon – Wikipedia entry on Epitalon, providing a general overview of its structure and reported biological activities.
    2. https://www.fda.gov/industry/regulated-products/food-and-drug-administration-fdas-regulation-research-use-only-ruo – FDA’s overview of the Research Use Only (RUO) designation, outlining regulatory considerations for peptide products.
    3. https://pubmed.ncbi.nlm.nih.gov/17472695/ – PubMed study (PMID 17472695) investigating Epitalon’s effects on telomere length and cellular senescence in vitro.
    4. https://pubmed.ncbi.nlm.nih.gov/23689633/ – PubMed article (PMID 23689633) examining Epitalon’s role in modulating circadian rhythms and sleep architecture research in animal models.

    Explore Our Complete Research Peptide Catalog

    Access 50+ research-grade compounds with verified purity documentation, COAs, and technical specifications.

    Third-Party Tested99%+ PurityFast Shipping
    Download CatalogBook a Call

Related Posts